Patent ID: 8877902

Claim:
A formulation for weight loss consisting essentially of: human chorionic gonadotrophin in an amount of from about 0.001 to about 0.1 weight percent; resveratrol in an amount of from about 1 to about 10 weight percent; lactose monohydrate (spray-dried) in an amount of from about 5 to about 20 weight percent; sodium stearyl fumarate in an amount of from about 1.5 to about 6 weight percent; a disintegrant in an amount of from about 60 to about 80 weight percent; a flavorant; and a sweetening agent, wherein the formulation is configured to be administered orally in the form of a tablet; wherein the formulation does not comprise silicon dioxide, colloidal silica, gel silica, precipitated silica, or any other flow agent, in an amount greater than approximately 1.05% by weight; and wherein an average disintegration time is less than approximately 60 seconds at about 37° C.